Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 studyÉric Pujade-Lauraine, Bradley J. Monk, Kan Yonemori et al.|The Lancet Oncology|2021Cited by 401
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified GuidelineVerna Vanderpuye, Rahel Ghebre, Jean R. Clemenceau et al.|JCO Global Oncology|2021Cited by 67
Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 TrialShoji Nagao, Takayuki Enomoto, Keiichi Fujiwara et al.|NEJM Evidence|2023Cited by 31
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical CancerKosei Hasegawa, Keiichi Fujiwara, Yuko Kunugi et al.|Journal of Immunotherapy|2018Cited by 30